CLINICAL_TRIALS
trial_result
· 2014-05-19
Clinical Trial Update: Cangrelor Ticagrelor Transition Study [Phase 2]
Summary
Phase 2 study evaluating transitioning from intravenous cangrelor to oral ticagrelor in coronary artery disease. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Medicines Company | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2014-05-19